APRICUS BIOSCIENCES, INC.·4

Apr 1, 7:19 PM ET

Martin Steven Robert 4

4 · APRICUS BIOSCIENCES, INC. · Filed Apr 1, 2013

Insider Transaction Report

Form 4
Period: 2013-03-31
Martin Steven Robert
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2013-03-31+1,3711,371 total
    Exercise: $2.68Exp: 2023-03-31Common Stock (1,371 underlying)
Footnotes (1)
  • [F1]The option is fully vested as of the date of grant.

Documents

1 file
  • 4
    rrd375669.xmlPrimary

    FORM 4